We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Guidance for prescribing vets on the use of the cascade.
The Commission on Human Medicines (CHM) has endorsed changes to the risk minimisation measures for isotretinoin, following a review of the impact of the measures implemented in 2023. We ask healthcare professionals to review these new measures and supporting materials...
Prescribing or supplying veterinary medicines including requirements for registration and inspection of premises.
Guidance for pharmacists on prescriptions issued in EU countries, Norway, Iceland, Liechtenstein and Switzerland.
How authorised veterinary medicines, products supplied under the cascade and products used under the Veterinary Medicines Internal Market Scheme and Veterinary Medicines Health Situation Scheme can be advertised.
Information about the reproductive risks of taking valproate medicines and the measures in place to reduce potential harm.
What veterinary businesses and veterinary professionals need to know now that the Competition and Markets Authority (CMA) has published the final report of its vet services market investigation.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).